1.
Ther Innov Regul Sci
; 50(4): 515-516, 2016 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30227014
RESUMO
Institutional review boards (IRBs) are one of the bodies charged with prospectively reviewing compassionate use, the hopefully therapeutic use of an unapproved drug in a seriously ill or dying patient who has no other treatment options. However, there are ethical issues in assigning this role to a body whose primary purpose is to review research proposals. The role of IRBs with regard to compassionate use must be examined and potentially revised.